Objective: To observe the efficacy of Qiju Dihuangwan on dry eye in patients after cataract operation and its effect on scores of tear breakup time (BUT)

schirmer I test (SIT)

and fluorescent test (FL). Method: The subjects of this study were selected from 116 cases of dry eye in patients after cataract surgery treated at our hospital from February 2016 to January 2017

and divided into two groups by means of random number table

with 58 cases (64 eyes) in observation group and 58 cases (66 eyes) in control group. Both groups were given artificial tears

and observation group was additionally given Qiju Dihuangwan. The clinical effects and the changes in BUT

SIT

FL and dry eye symptom scores of two groups were compared. Result: The overall effective rate of the observation group was 93.75%

which was significantly higher than 77.27% of control group (P<0.01). Two 2 weeks

1 month

3 months later after operation

BUT in both groups was obviously prolonged (P<0.01)

while the increase at each time point in observation group was more evident (P<0.05). Two 2 weeks

1 month

3 months later after operation

SIL in both groups was increased markedly (P<0.01)

while the increase at each time point in observation group was more significant (P<0.05). Two 2 weeks

1 month

3 months later after operation

FL in two groups decreased (P<0.01)

while the decrease was more significant in observation group (P<0.01). Two 2 weeks

1 month

3 months later after operation

the symptom scores also decreased remarkably (P<0.01)

while the decrease in observation group was more significant (P<0.01). Conclusion: In the treatment of dry eye in patients after cataract surgery

Qiju Dihuangwan has a curative effect in improving the stability of tear film and the visual function.